Shares of the developmental-stage biotech Trillium Therapeutics (TRIL +0.00%) are up by a whopping 192% in pre-market trading Monday morning. The cancer company's stock is surging this morning in ...
I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...
Headquartered in Houston, Trillium is a provider of flow control products and aftermarket services; Flowserve is a provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results